SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-201244
Filing Date
2014-05-15
Accepted
2014-05-15 16:26:59
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d715535d10q.htm 10-Q 293884
2 EX-31.1 d715535dex311.htm EX-31.1 8398
3 EX-31.2 d715535dex312.htm EX-31.2 8377
4 EX-32.1 d715535dex321.htm EX-32.1 3826
5 EX-32.2 d715535dex322.htm EX-32.2 3811
  Complete submission text file 0001193125-14-201244.txt   3117110

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20140331.xml EX-101.INS 385718
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20140331.xsd EX-101.SCH 41770
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20140331_cal.xml EX-101.CAL 49462
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20140331_def.xml EX-101.DEF 107108
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20140331_lab.xml EX-101.LAB 293377
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20140331_pre.xml EX-101.PRE 197351
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 14847737
SIC: 2834 Pharmaceutical Preparations